Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1972 1
1974 2
1978 1
1980 1
1981 2
1984 2
1985 1
1988 1
1992 1
1994 2
1995 1
1997 1
1999 1
2000 2
2001 3
2002 3
2003 2
2004 3
2005 1
2006 6
2007 4
2008 8
2009 10
2010 6
2011 12
2012 16
2013 8
2014 11
2015 11
2016 11
2017 12
2018 6
2019 8
2020 15
2021 24
2022 14
Text availability
Article attribute
Article type
Publication date

Search Results

186 results
Results by year
Filters applied: . Clear all
Page 1
Sacituzumab govitecan, a Trop-2-directed antibody-drug conjugate, for patients with epithelial cancer: final safety and efficacy results from the phase I/II IMMU-132-01 basket trial.
Bardia A, Messersmith WA, Kio EA, Berlin JD, Vahdat L, Masters GA, Moroose R, Santin AD, Kalinsky K, Picozzi V, O'Shaughnessy J, Gray JE, Komiya T, Lang JM, Chang JC, Starodub A, Goldenberg DM, Sharkey RM, Maliakal P, Hong Q, Wegener WA, Goswami T, Ocean AJ. Bardia A, et al. Among authors: goswami t. Ann Oncol. 2021 Jun;32(6):746-756. doi: 10.1016/j.annonc.2021.03.005. Epub 2021 Mar 16. Ann Oncol. 2021. PMID: 33741442 Free article. Clinical Trial.
TROPHY-U-01: A Phase II Open-Label Study of Sacituzumab Govitecan in Patients With Metastatic Urothelial Carcinoma Progressing After Platinum-Based Chemotherapy and Checkpoint Inhibitors.
Tagawa ST, Balar AV, Petrylak DP, Kalebasty AR, Loriot Y, Fléchon A, Jain RK, Agarwal N, Bupathi M, Barthelemy P, Beuzeboc P, Palmbos P, Kyriakopoulos CE, Pouessel D, Sternberg CN, Hong Q, Goswami T, Itri LM, Grivas P. Tagawa ST, et al. Among authors: goswami t. J Clin Oncol. 2021 Aug 1;39(22):2474-2485. doi: 10.1200/JCO.20.03489. Epub 2021 Apr 30. J Clin Oncol. 2021. PMID: 33929895 Free PMC article. Clinical Trial.
Sacituzumab govitecan in previously treated hormone receptor-positive/HER2-negative metastatic breast cancer: final results from a phase I/II, single-arm, basket trial.
Kalinsky K, Diamond JR, Vahdat LT, Tolaney SM, Juric D, O'Shaughnessy J, Moroose RL, Mayer IA, Abramson VG, Goldenberg DM, Sharkey RM, Maliakal P, Hong Q, Goswami T, Wegener WA, Bardia A. Kalinsky K, et al. Among authors: goswami t. Ann Oncol. 2020 Dec;31(12):1709-1718. doi: 10.1016/j.annonc.2020.09.004. Epub 2020 Sep 15. Ann Oncol. 2020. PMID: 32946924 Free article. Clinical Trial.
A tissue-specific atlas of mouse protein phosphorylation and expression.
Huttlin EL, Jedrychowski MP, Elias JE, Goswami T, Rad R, Beausoleil SA, Villén J, Haas W, Sowa ME, Gygi SP. Huttlin EL, et al. Among authors: goswami t. Cell. 2010 Dec 23;143(7):1174-89. doi: 10.1016/j.cell.2010.12.001. Cell. 2010. PMID: 21183079 Free PMC article.
Piper nigrum and piperine: an update.
Meghwal M, Goswami TK. Meghwal M, et al. Among authors: goswami tk. Phytother Res. 2013 Aug;27(8):1121-30. doi: 10.1002/ptr.4972. Epub 2013 Apr 29. Phytother Res. 2013. PMID: 23625885 Review.
Sublingual drug delivery.
Goswami T, Jasti B, Li X. Goswami T, et al. Crit Rev Ther Drug Carrier Syst. 2008;25(5):449-84. doi: 10.1615/critrevtherdrugcarriersyst.v25.i5.20. Crit Rev Ther Drug Carrier Syst. 2008. PMID: 19062634 Review.
The sarcoid-lymphoma syndrome.
Goswami T, Siddique S, Cohen P, Cheson BD. Goswami T, et al. Clin Lymphoma Myeloma Leuk. 2010 Aug;10(4):241-7. doi: 10.3816/CLML.2010.n.052. Clin Lymphoma Myeloma Leuk. 2010. PMID: 20709659 Review.
Transporters as channels.
DeFelice LJ, Goswami T. DeFelice LJ, et al. Among authors: goswami t. Annu Rev Physiol. 2007;69:87-112. doi: 10.1146/annurev.physiol.69.031905.164816. Annu Rev Physiol. 2007. PMID: 17059369 Review.
186 results